East Asia & Pacific (IDA & IBRD countries) vs Kazakhstan: Immunization, HepB3
Immunization, HepB3 over time
- East Asia & Pacific (IDA & IBRD countries)
- Kazakhstan
How they compare
Kazakhstan currently reports 98.0% against 87.2% in East Asia & Pacific (IDA & IBRD countries), a difference of 10.8%.
That makes Kazakhstan's figure about 1.1 times East Asia & Pacific (IDA & IBRD countries)'s.
The two have swapped places 4 times across 27 shared years of data; in 1998 it was Kazakhstan ahead.
East Asia & Pacific (IDA & IBRD countries) ranks 17th and Kazakhstan ranks 19th of 47 groups.
Kazakhstan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | East Asia & Pacific (IDA & IBRD countries) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 20.4% | 69.5% | 49.1% | Kazakhstan |
| 2000s | 74.7% | 97.2% | 22.5% | Kazakhstan |
| 2010s | 93.7% | 96.2% | 2.5% | Kazakhstan |
| 2020s | 89.0% | 95.4% | 6.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, East Asia & Pacific (IDA & IBRD countries) or Kazakhstan?
- Kazakhstan, at 98.0% against 87.2% in East Asia & Pacific (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between East Asia & Pacific (IDA & IBRD countries) and Kazakhstan?
- 10.8%, with Kazakhstan ahead.
- How many years of comparable data are there for East Asia & Pacific (IDA & IBRD countries) and Kazakhstan?
- 27 years are reported by both, from 1998 to 2024.
- How do East Asia & Pacific (IDA & IBRD countries) and Kazakhstan rank globally for immunization, hepb3?
- East Asia & Pacific (IDA & IBRD countries) ranks 17th and Kazakhstan ranks 19th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.